Published online 18 February 2004
Nucleic Acids Research, 2004, Vol. 32, No. 3 1214-1223
© 2004 Oxford University Press
Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin–Lowry syndrome
Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, CU de Strasbourg, BP 10142, 67404 Illkirch Cedex, France
*To whom correspondence should be addressed. Tel: +33 3 88 65 33 61; Fax: +33 3 88 65 32 01; Email: stevenin{at}igbmc.u-strasbg.fr
Present address:
Maria Zeniou, Centre de Neurochimie, 5 Rue Blaise Pascal, 67084 Strasbourg Cedex, France
Coffin–Lowry syndrome (CLS) is caused by mutations in the RSK2 gene encoding a protein kinase of the Ras signalling pathway. We have studied two point mutations which cause aberrant splicing but do not concern the invariant GT or AG nucleotides of splice sites. The first, an A
G transition at position +3 of the 5' splice site of exon 6, results in vivo and in vitro in exon skipping and premature translation termination. The natural 5' splice site, although intrinsically weak, is not transactivated under normal conditions. Consequently, replacement of an A/U by a G/U base pairing with U1 snRNA reduces its strength below a critical threshold. The second mutation, an AG transition 11 nt upstream of exon 5, creates a new AG near the natural 3' splice site. In vitro this synthetic 3' AG is used exclusively by the splicing machinery. In vivo this splicing event is also observed, but is underestimated because the resulting RSK2 mRNA contains premature stop codons which trigger the nonsense-mediated decay process. We show that a particular mechanism is involved in the aberrant splicing of exon 5, implying involvement of the natural 3' AG during the first catalytic step and the new 3' AG during the second step. Thus, our results explain how these mutations cause severe forms of CLS.